Zogenix, Inc. (ZGNX): Price and Financial Metrics
Zogenix, Inc. (ZGNX)
Today's Latest Price: $21.29 USD
Updated Oct 23 6:55pm
Add ZGNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ZGNX Stock Summary
- With a price/sales ratio of 233.88, Zogenix Inc has a higher such ratio than 98.23% of stocks in our set.
- Over the past twelve months, ZGNX has reported earnings growth of 221.86%, putting it ahead of 94.01% of US stocks in our set.
- Revenue growth over the past 12 months for Zogenix Inc comes in at 354.63%, a number that bests 98.1% of the US stocks we're tracking.
- Stocks that are quantitatively similar to ZGNX, based on their financial statements, market capitalization, and price volatility, are CMRX, ABUS, CSLT, AGYS, and RBBN.
- Visit ZGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.zogenix.com.
ZGNX Stock Price Chart Interactive Chart >
ZGNX Price/Volume Stats
| Current price | $21.29 | 52-week high | $57.22 |
| Prev. close | $21.00 | 52-week low | $16.65 |
| Day low | $20.63 | Volume | 857,600 |
| Day high | $21.30 | Avg. volume | 1,132,534 |
| 50-day MA | $21.51 | Dividend yield | N/A |
| 200-day MA | $27.89 | Market Cap | 1.18B |
Zogenix, Inc. (ZGNX) Company Bio
Zogenix develops and commercializes therapies for the treatment of central nervous system disorders. The company was founded in 2006 and is based in San Diego, California.
Loading social stream, please wait...